COEP Past Earnings image   This COEP past earnings page last updated 5/14/2024
COEP Past Earnings
PeriodPast Earnings DateGAAP
Q1 20245/10/2024-0.080
Q4 20233/26/2024-0.080
Q3 202311/9/2023-0.230
Q2 20238/11/2023-0.140
Q1 20235/15/2023-0.390
Q4 20223/29/2023-3.020
Q3 202211/18/2022-0.060
COEP Past Revenue
PeriodPast Earnings DateGAAP
Q1 20245/10/2024NA
Q4 20233/26/2024NA
Q3 202311/9/2023NA
Q2 20238/11/2023NA
Q1 20235/15/2023NA
Q4 20223/29/2023NA
Q3 202211/18/2022NA

COEP Past Earnings Q&A

What was the best and worst COEP past earnings results?
For Coeptis Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest COEP past earnings result in our data set was -0.060/share posted in Q3 2022, while the lowest was in Q4 2022 when COEP posted -3.020/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2024 when COEP reported NA in revenue, while the quarter with the lowest revenue in our data set was Q1 2024 at NA of revenue.

  Suggested answer: There are 7 COEP past earnings results in our data set.

On this page we presented the COEP past earnings date information for Coeptis Therapeutics. Reviewing that COEP Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2022, when COEP posted gaap of -0.060/share. Meanwhile the lowest COEP past earnings result was in Q4 2022, when COEP posted gaap of -3.020/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2024 when COEP reported NA in revenue, while the smallest revenue quarter was Q1 2024 when COEP reported NA in revenue.

Any self directed investor doing their due diligence on COEP or any other given stock can benefit from researching all of the Coeptis Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Coeptis Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for COEP. Thanks for visiting, and the next time you need to research COEP past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Top Ten Hedge Funds Holding ESGY, FRTA Options Chain, Funds Holding APIE.

 

COEP Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.